(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APS ADVANCED PHARMACY SOLUTIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

APS ADVANCED PHARMACY SOLUTIONS

ST13

US500000090509911

Class

42

Filing

90509911

Registration

6804927

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

01/26/2023

Trademark type

Combined

Nice classes

42

Filing date

02/04/2021

Registration date

07/26/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/26/2022

Last transaction

07/26/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2021-03-00

First use in commerce

2021-03-00

Drawing code

3

Owner type

16

Owner location

Fort Lee, NJ

Examiner

STEEL, ALYSSA

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "APS ADVANCED PHARMACY SOLUTIONS". The letters "APS" appear in gray capital letters in the center of the mark. The words "ADVANCED PHARMACY SOLUTIONS" appear to the right of the letters "APS" on three lines in smaller gray capital block letters. Four blue capsules and eight blue tablets appear to the left of the letters "APS" and form a stylized square design. The color white is not claimed as a feature of the mark.

Holders and representatives

Holders

TotalCare, LLC

Representatives

Peter Nussbaum CHIESA SHAHINIAN & GIANTOMASI PC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing quality control services for othersremote electronic monitoring via the internet using computers and sensors and remote visual monitoring via the internet of drug dispensing equipment using computers and sensors for the purposes of assisting medical personnel in ensuring accuracy in drug dispensing

Publications

History of USPTO decisions and trademark events.

24 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/26/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/26/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/26/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/26/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/26/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/22/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/21/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/17/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/17/2022

IUAF

USE AMENDMENT FILED

05/31/2022

EISU

TEAS STATEMENT OF USE RECEIVED

05/31/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/30/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/05/2021

PUBO

PUBLISHED FOR OPPOSITION

10/05/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/15/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/02/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

09/01/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/01/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

09/01/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/01/2021

DOCK

ASSIGNED TO EXAMINER

08/26/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/08/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/07/2021

NWAP

NEW APPLICATION ENTERED

02/08/2021

Continuous trademark protection

Get notified about every new filing that threatens APS ADVANCED PHARMACY SOLUTIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.